Safety profile of semaglutide versus placebo in the <scp>SELECT</scp> study: a randomized controlled trial

The long-term safety profile observed in the Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity (SELECT) study is consistent with previously reported semaglutide studies. No new safety concerns were identified for once-weekly semaglutide 2.4 mg.

Authors

Institutions

Publication Details

Journal
Obesity
Published
2025-02-13
DOI
https://doi.org/10.1002/oby.24222
Citations
16
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
20.72

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial

Ildiko Lingvay, A. Michael Lincoff, Chau‐Chung Wu, Petra Weimers et al.
16 citations
Obesity
Diabetes Treatment and Management
20.72
article

Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial

Ildiko Lingvay, A. Michael Lincoff, Chau‐Chung Wu, Petra Weimers, John P.H. Wilding, Ole Kleist Jeppesen, Robert F. Kushner, Cíntia Cercato, Nina M. Harder‐Lauridsen, Klaus Kallenbach, Anca-Elena Crăciun, Jøran Hjelmesæth, Bartolomé Burguera, Alexander Kokkinos, Donna H. Ryan, Irene Hramiak, John Deanfield, Dénes Páll
article en
16 citations

Abstract

The long-term safety profile observed in the Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity (SELECT) study is consistent with previously reported semaglutide studies. No new safety concerns were identified for once-weekly semaglutide 2.4 mg.

ObesityVol. 33(3)
Pennington Biomedical Research Center (US), Northwestern University (US), Western University (CA), Cleveland Clinic (US), University of Debrecen (HU), University of Liverpool (GB), University of Oslo (NO), Novo Nordisk (Denmark) (DK), National and Kapodistrian University of Athens (GR), Iuliu Hațieganu University of Medicine and Pharmacy (RO), Sykehuset i Vestfold (NO), Cleveland Clinic Lerner College of Medicine (US), National Taiwan University Hospital (TW), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR), Spitalul Clinic Județean de Urgență Cluj-Napoca (RO), Southwestern Medical Center (US), University College London (GB), Case Western Reserve University (US), The University of Texas Southwestern Medical Center (US)
Novo Nordisk
Good health and well-being
Openalex Percentile: Top 1%
Diabetes Treatment and Management
20.72
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.